[
  {
    "ts": null,
    "headline": "Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and EHA",
    "summary": "FOSTER CITY, Calif. & SANTA MONICA, Calif., May 15, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting May 30 – June 3 and the 2025 European Hematology Association (EHA) Annual Congress June 12 – 15. The studies span breast cancer and other solid tumors (glioblastoma, endometrial cancer, lung cancer, gastric cancer), as well as multiple blood cancers (multiple",
    "url": "https://finnhub.io/api/news?id=bb275b560691c35ddc84eed505baaf5c9edc63235b2a580b33f07c0a30da52f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747340100,
      "headline": "Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and EHA",
      "id": 134498812,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "FOSTER CITY, Calif. & SANTA MONICA, Calif., May 15, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting May 30 – June 3 and the 2025 European Hematology Association (EHA) Annual Congress June 12 – 15. The studies span breast cancer and other solid tumors (glioblastoma, endometrial cancer, lung cancer, gastric cancer), as well as multiple blood cancers (multiple",
      "url": "https://finnhub.io/api/news?id=bb275b560691c35ddc84eed505baaf5c9edc63235b2a580b33f07c0a30da52f4"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=732a6565a628d1200e73d87164b4606a244268a081df5d595d891f3cb1e1017f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747327020,
      "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 134490070,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=732a6565a628d1200e73d87164b4606a244268a081df5d595d891f3cb1e1017f"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences: Bringing PBC Into Focus Through Art of Patient Stories",
    "summary": "NORTHAMPTON, MA / ACCESS Newswire / May 15, 2025 / \"Living with primary biliary cholangitis (PBC) can be an isolating experience,\" explains Dilek, a mother of two from Germany who suffers from the rare chronic liver disease. \"All the Feelings with ...",
    "url": "https://finnhub.io/api/news?id=4f646d6da37152c38ee77c08e2222bc3f6f567bd7ea11ef0e6d8619b0d52d1e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747315500,
      "headline": "Gilead Sciences: Bringing PBC Into Focus Through Art of Patient Stories",
      "id": 134483767,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "NORTHAMPTON, MA / ACCESS Newswire / May 15, 2025 / \"Living with primary biliary cholangitis (PBC) can be an isolating experience,\" explains Dilek, a mother of two from Germany who suffers from the rare chronic liver disease. \"All the Feelings with ...",
      "url": "https://finnhub.io/api/news?id=4f646d6da37152c38ee77c08e2222bc3f6f567bd7ea11ef0e6d8619b0d52d1e5"
    }
  },
  {
    "ts": null,
    "headline": "Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?",
    "summary": "Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=35bafc7c7c31a68a90d8c19c406ac7379579e8aab7f93d4f642d81b59b36dd21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747314012,
      "headline": "Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?",
      "id": 134483768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=35bafc7c7c31a68a90d8c19c406ac7379579e8aab7f93d4f642d81b59b36dd21"
    }
  }
]